Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
03/30/2010 | US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
03/30/2010 | US7687508 Cyclic derivatives as modulators of chemokine receptor activity |
03/30/2010 | US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes |
03/30/2010 | US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders |
03/30/2010 | US7687502 Substituted quinazoline or pyridopyrimidine derivative |
03/30/2010 | US7687481 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
03/30/2010 | CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
03/30/2010 | CA2445395C Heterocyclic compound and antitumor agent comprising the same as effective component |
03/30/2010 | CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
03/30/2010 | CA2306429C Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
03/25/2010 | WO2010033977A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
03/25/2010 | WO2010033678A2 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
03/25/2010 | WO2010033643A2 Small molecule compounds for stem cell differentiation |
03/25/2010 | WO2010033593A2 Rosin derived epoxides and curing agents |
03/25/2010 | WO2010033543A2 Novel compounds as cannabinoid receptor ligands |
03/25/2010 | WO2010032901A1 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition comprising the same as active ingredient |
03/25/2010 | WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same |
03/25/2010 | WO2010032200A1 Amide compounds useful in therapy |
03/25/2010 | WO2010031852A1 Novel estrogen receptor ligands |
03/25/2010 | WO2010031713A1 Substituted pyrrolidine-2-carboxamides |
03/25/2010 | WO2010011367A3 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
03/25/2010 | WO2010009405A9 Targeted nitroxide agents |
03/25/2010 | US20100077512 Pyridazin-4-ylmethyl-sulfonamides used as Fungicides and Against Arthropods |
03/25/2010 | US20100076202 Method for producing pyrrolidine derivative |
03/25/2010 | US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
03/25/2010 | US20100075991 Post-translational regulation of catalytic activities of cytochrome P450 46A1 and uses thereof |
03/25/2010 | US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis |
03/25/2010 | US20100075976 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
03/25/2010 | US20100075970 Inhibitors of akt activity |
03/25/2010 | US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators |
03/25/2010 | US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders |
03/25/2010 | US20100075966 Substituted Dihydroimidazoles and their Use in the Treatment of Tumors |
03/25/2010 | US20100075956 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
03/25/2010 | US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
03/25/2010 | US20100075949 Novel pyrrolidin-2-ones |
03/25/2010 | US20100075948 Substituted Pyrrolidine-2-Carboxamides |
03/25/2010 | US20100075911 Dimeric iap inhibitors |
03/25/2010 | US20100075348 Method for diagnosis of a disease involving an anti-endothelin-receptor antibody |
03/25/2010 | US20100074842 Technetium-99m (I) Tricarbonyl Complexes with Tridentate Chelators for Myocardium Imaging |
03/25/2010 | US20100074083 Resin composition and molded product obtained by molding the resin composition |
03/25/2010 | CA2770302A1 Small molecule compounds for stem cell differentiation |
03/25/2010 | CA2737199A1 Novel compounds as cannabinoid receptor ligands |
03/25/2010 | CA2736955A1 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
03/25/2010 | CA2735931A1 Amide compounds useful in therapy |
03/25/2010 | CA2734363A1 Substituted pyrrolidine-2-carboxamides |
03/24/2010 | EP2165709A2 Lysine based compounds |
03/24/2010 | EP2164844A1 Pyrimidinyl pyridazinone derivates |
03/24/2010 | EP2164843A1 Pyridazinone derivates |
03/24/2010 | EP2164833A2 Quinazolinamide derivatives |
03/24/2010 | EP1751104B1 Synthesis methods and intermediates for the manufacture of rizatriptan |
03/24/2010 | EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
03/24/2010 | CN101679400A Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
03/24/2010 | CN101679387A Aminopyrimidines useful as kinase inhibitors |
03/24/2010 | CN101679386A Aminopyrimidines useful as kinase inhibitors |
03/24/2010 | CN101679385A Prolinamide-tetrazole derivatives as NK3 receptor antagonists |
03/24/2010 | CN101679384A Novel amide derivative for inhibiting the growth of cancer cells |
03/24/2010 | CN101679383A Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative |
03/24/2010 | CN101679382A 3-imidazolyl-indoles for the treatment of proliferative diseases |
03/24/2010 | CN101679381A Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
03/24/2010 | CN101679380A 4'-o-substituted isoindoline derivatives and compositions compositions comprising and methods of using the same |
03/24/2010 | CN101679379A arylamide pyrimidone compounds |
03/24/2010 | CN101679377A Heterocyclic hydrazide compound and pesticidal use of the same |
03/24/2010 | CN101679371A Substituted pyrimidines as adenosine receptor antagonists |
03/24/2010 | CN101679367A Therapeutic agent for cerebral infarction |
03/24/2010 | CN101679365A Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
03/24/2010 | CN101679364A heteroarylamide pyrimidone compounds |
03/24/2010 | CN101679358A Pyrrole derivatives as p2y12 antagonists |
03/24/2010 | CN101679354A Novel triazinedione derivatives as GABAB receptor modulators |
03/24/2010 | CN101679350A Quinoline derivatives for the treatment of inflammatory diseases |
03/24/2010 | CN101679319A Triazole compounds that modulate hsp90 activity |
03/24/2010 | CN101679318A Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry |
03/24/2010 | CN101679310A Alkynylpyrimidines as Tie2 kinase inhibitors |
03/24/2010 | CN101679309A Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
03/24/2010 | CN101679308A inhibitors of the hedgehog pathway |
03/24/2010 | CN101679306A Heteroarylamide pyrimidone derivatives |
03/24/2010 | CN101679304A Pyridazine-, pyridine- and pyrane-derivatives as GPBAR1 agonisis |
03/24/2010 | CN101679303A pyridazinone derivatives |
03/24/2010 | CN101679299A Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
03/24/2010 | CN101679291A Imidazolidine carboxamide derivatives as P2X7 modulators |
03/24/2010 | CN101679287A nicotinic acetylcholine receptor modulators |
03/24/2010 | CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
03/24/2010 | CN101679276A Isoquinolinone derivatives as nk3 antagonists |
03/24/2010 | CN101679250A Ppar活性化合物 Ppar active compounds |
03/24/2010 | CN101679249A Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
03/24/2010 | CN101679237A processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof |
03/24/2010 | CN101679235A Azetidine derivatives and their use as prostaglandin E2 antagonists |
03/24/2010 | CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth |
03/24/2010 | CN101678214A 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones |
03/24/2010 | CN101678020A Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases |
03/24/2010 | CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine |
03/24/2010 | CN101676264A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
03/23/2010 | US7683201 cost efficiency; environmentally friendly |
03/23/2010 | US7683093 N-1-[(4-chlorophenyl)]-N-2-{[4-(2{dimethylaminomethyl }phenyl)phenyl]-}-(2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxamide; inhibitors of coagulation factor Xa; thromboembolic diseases; tumors |
03/23/2010 | US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3) |
03/23/2010 | US7683061 rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis; reduced drug toxicity |
03/23/2010 | US7683060 3-[1-(4-Methoxyphenyl)cyclopropyl]-6-phenyl[1,2,4]triazolo[4,3-b][1,2,4]triazine; cancer and other diseases related to the dysregulation of kinase pathways; c-Met inhibitors |
03/23/2010 | US7683059 Triazole compounds and uses related thereto |
03/23/2010 | US7683052 Crystalline polymorph of bazedoxifene acetate |
03/23/2010 | US7683051 Crystalline polymorph of bazedoxifene acetate |